Stock Events

Stock Events

Inhibikase Therapeutics (IKT) Q2 2026 Earnings

18MayConfirmed

Q3 2025

Q4 2025

Q1 2026

Next

-0.13

-0.11

-0.1

-0.08

Details

Expected EPS

-0.108333

Actual EPS

N/A

Surprise EPS

0.11

Surprise Percent

+100%

Description

Inhibikase Therapeutics (IKT) will report earnings of for Q2 2026 on May 18, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.